BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ge H, Luo H. Overview of advances in vasculogenic mimicry - a potential target for tumor therapy. Cancer Manag Res 2018;10:2429-37. [PMID: 30122992 DOI: 10.2147/CMAR.S164675] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 12.2] [Reference Citation Analysis]
Number Citing Articles
1 Wälchli T, Bisschop J, Carmeliet P, Zadeh G, Monnier PP, De Bock K, Radovanovic I. Shaping the brain vasculature in development and disease in the single-cell era. Nat Rev Neurosci 2023;:1-28. [PMID: 36941369 DOI: 10.1038/s41583-023-00684-y] [Reference Citation Analysis]
2 Kicman A, Niczyporuk M, Kulesza M, Motyka J, Ławicki S. Utility of Matrix Metalloproteinases in the Diagnosis, Monitoring and Prognosis of Ovarian Cancer Patients. CMAR 2022;Volume 14:3359-3382. [DOI: 10.2147/cmar.s385658] [Reference Citation Analysis]
3 Giusti I, Poppa G, D’ascenzo S, Esposito L, Vitale AR, Calvisi G, Dolo V. Cancer Three-Dimensional Spheroids Mimic In Vivo Tumor Features, Displaying “Inner” Extracellular Vesicles and Vasculogenic Mimicry. IJMS 2022;23:11782. [DOI: 10.3390/ijms231911782] [Reference Citation Analysis]
4 Parvathaneni V, Chilamakuri R, Kulkarni NS, Baig NF, Agarwal S, Gupta V. Exploring Amodiaquine’s Repurposing Potential in Breast Cancer Treatment—Assessment of In-Vitro Efficacy & Mechanism of Action. IJMS 2022;23:11455. [DOI: 10.3390/ijms231911455] [Reference Citation Analysis]
5 Qin Y, Zhao W, Cai Z, Wang Q, Gao J, Ci H, Feng Z, Ma L, Muddassir Ali M. The Biomarker Like the Correlation between Vasculogenic Mimicry, Vascular Endothelial Cadherin, Sex-DeterminingRegion on Y-Box Transcription Factor 17, and Cyclin D1 in Oesophageal Squamous Cell Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/8915503] [Reference Citation Analysis]
6 Khater M, Watson KA, Boateng SY, Greco F, Osborn HMI. Halogenated Flavonoid Derivatives Display Antiangiogenic Activity. Molecules 2022;27:4757. [PMID: 35897938 DOI: 10.3390/molecules27154757] [Reference Citation Analysis]
7 Kicman A, Kołos J, Motyka J, Kulesza M, Niczyporuk M, Szmitkowski M, Ławicki S. The utility of metalloprotienase 9 (MMP-9) in diagnostics of ovarian cancer. Diagn Lab 2022;57:179-187. [DOI: 10.5604/01.3001.0015.8844] [Reference Citation Analysis]
8 Liu X, He H, Zhang F, Hu X, Bi F, Li K, Yu H, Zhao Y, Teng X, Li J, Wang L, Zhang Y, Wu Q. m6A methylated EphA2 and VEGFA through IGF2BP2/3 regulation promotes vasculogenic mimicry in colorectal cancer via PI3K/AKT and ERK1/2 signaling. Cell Death Dis 2022;13:483. [PMID: 35595748 DOI: 10.1038/s41419-022-04950-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
9 Ruan L, Zhang S, Chen X, Liang W, Xie Q. Role of Anti-Angiogenic Factors in the Pathogenesis of Breast Cancer: A Review of Therapeutic Potential. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153956] [Reference Citation Analysis]
10 Liang C, Yang L, Guo SW, Li RC. Downregulation of Astrocyte Elevated Gene-1 Expression Combined with All-Trans Retinoic Acid Inhibits Development of Vasculogenic Mimicry and Angiogenesis in Glioma. Curr Med Sci 2022;42:397-406. [PMID: 35201552 DOI: 10.1007/s11596-022-2517-4] [Reference Citation Analysis]
11 Souza JC, Bastos VC, Pereira NB, Dias AAM, Avelar GF, Gomez RS, Gomes CC. Angiogenesis in patient-derived xenografts of odontogenic myxoma. Int J Exp Pathol 2022. [PMID: 35225401 DOI: 10.1111/iep.12431] [Reference Citation Analysis]
12 Sun F, Jie Q, Li Q, Wei Y, Li H, Yue X, Ma Y. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway. J Cell Mol Med 2022. [PMID: 35137520 DOI: 10.1111/jcmm.17204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Han D, Lee E. Sp1 Plays a Key Role in Vasculogenic Mimicry of Human Prostate Cancer Cells. IJMS 2022;23:1321. [DOI: 10.3390/ijms23031321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Manarang JC, Mcdermott A. Evaluation of Pharmaceutical Inhibition of Vasculogenic Mimicry In Vitro. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2403-6_13] [Reference Citation Analysis]
15 de Andrade Peixoto M, Marques dos Reis E, Marques Porto L. Cancer Cell Spheroids as a 3D Model for Exploring the Pathobiology of Vasculogenic Mimicry. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2403-6_5] [Reference Citation Analysis]
16 Biagioni A, Andreucci E. Immunohistochemistry for VM Markers. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2403-6_14] [Reference Citation Analysis]
17 Harry JA, Ormiston ML. Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer. Front Oncol 2021;11:772305. [PMID: 34926282 DOI: 10.3389/fonc.2021.772305] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Cocola C, Magnaghi V, Abeni E, Pelucchi P, Martino V, Vilardo L, Piscitelli E, Consiglio A, Grillo G, Mosca E, Gualtierotti R, Mazzaccaro D, La Sala G, Di Pietro C, Palizban M, Liuni S, DePedro G, Morara S, Nano G, Kehler J, Greve B, Noghero A, Marazziti D, Bussolino F, Bellipanni G, D'Agnano I, Götte M, Zucchi I, Reinbold R. Transmembrane Protein TMEM230, a Target of Glioblastoma Therapy. Front Cell Neurosci 2021;15:703431. [PMID: 34867197 DOI: 10.3389/fncel.2021.703431] [Reference Citation Analysis]
19 Charfi C, Demeule M, Currie JC, Larocque A, Zgheib A, Danalache BA, Ouanouki A, Béliveau R, Marsolais C, Annabi B. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells. Front Oncol 2021;11:760787. [PMID: 34751242 DOI: 10.3389/fonc.2021.760787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Herrera-Vargas AK, García-Rodríguez E, Olea-Flores M, Mendoza-Catalán MA, Flores-Alfaro E, Navarro-Tito N. Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer. Cytokine Growth Factor Rev 2021:S1359-6101(21)00078-2. [PMID: 34736827 DOI: 10.1016/j.cytogfr.2021.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Xu Y, Fu L, Pan D, Wei J, Xia H, Wang S, Sun G. Folic Acid Inhibited Vasculogenic Mimicry in Esophageal Cancer Cell Line Eca-109, the One Target Was EphA2. Nutr Cancer 2021;:1-8. [PMID: 34678082 DOI: 10.1080/01635581.2021.1988992] [Reference Citation Analysis]
22 Shao Y, Lu B. The emerging roles of circular RNAs in vessel co-option and vasculogenic mimicry: clinical insights for anti-angiogenic therapy in cancers. Cancer Metastasis Rev 2021. [PMID: 34664157 DOI: 10.1007/s10555-021-10000-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Massimini M, Romanucci M, De Maria R, Della Salda L. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Front Vet Sci 2021;8:722432. [PMID: 34631854 DOI: 10.3389/fvets.2021.722432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Aspriţoiu VM, Stoica I, Bleotu C, Diaconu CC. Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment. Front Cell Dev Biol 2021;9:689962. [PMID: 34552922 DOI: 10.3389/fcell.2021.689962] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
25 Fouladzadeh A, Dorraki M, Min KKM, Cockshell MP, Thompson EJ, Verjans JW, Allison A, Bonder CS, Abbott D. The development of tumour vascular networks. Commun Biol 2021;4:1111. [PMID: 34552183 DOI: 10.1038/s42003-021-02632-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
26 Thankamony AP, Subbalakshmi AR, Jolly MK, Nair R. Lineage Plasticity in Cancer: The Tale of a Skin-Walker. Cancers (Basel) 2021;13:3602. [PMID: 34298815 DOI: 10.3390/cancers13143602] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
27 Braun A, Anders HJ, Gudermann T, Mammadova-Bach E. Platelet-Cancer Interplay: Molecular Mechanisms and New Therapeutic Avenues. Front Oncol 2021;11:665534. [PMID: 34322381 DOI: 10.3389/fonc.2021.665534] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 8.5] [Reference Citation Analysis]
28 Upcin B, Henke E, Kleefeldt F, Hoffmann H, Rosenwald A, Irmak-Sav S, Aktas HB, Rückschloß U, Ergün S. Contribution of Adventitia-Derived Stem and Progenitor Cells to New Vessel Formation in Tumors. Cells 2021;10:1719. [PMID: 34359889 DOI: 10.3390/cells10071719] [Reference Citation Analysis]
29 Haas G, Fan S, Ghadimi M, De Oliveira T, Conradi LC. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases. Front Cell Dev Biol 2021;9:612774. [PMID: 33912554 DOI: 10.3389/fcell.2021.612774] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
30 Almahmoudi R, Salem A, Hadler-Olsen E, Svineng G, Salo T, Al-Samadi A. The effect of interleukin-17F on vasculogenic mimicry in oral tongue squamous cell carcinoma. Cancer Sci 2021;112:2223-32. [PMID: 33743555 DOI: 10.1111/cas.14894] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Pereira SS, Oliveira S, Monteiro MP, Pignatelli D. Angiogenesis in the Normal Adrenal Fetal Cortex and Adrenocortical Tumors. Cancers (Basel) 2021;13:1030. [PMID: 33804534 DOI: 10.3390/cancers13051030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo Y, Ren D, Hua Y, Yu B, Zhou Y, Liao Q, Wang H, Xiang B, Zhou M, Li X, Li G, Li Y, Xiong W, Zeng Z. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer 2021;20:7. [PMID: 33397409 DOI: 10.1186/s12943-020-01288-1] [Cited by in Crossref: 59] [Cited by in F6Publishing: 75] [Article Influence: 29.5] [Reference Citation Analysis]
33 Fajardo-orduña G, Chamorro-plata D. Molecular and therapeutic bases of cancer. Oncological Functional Nutrition 2021. [DOI: 10.1016/b978-0-12-819828-5.00002-4] [Reference Citation Analysis]
34 Garza Treviño EN, Delgado-gonzalez P, Valencia Salgado CI, Ortega Garcia JL. Pericytes Relationship with Cancer Stem Cells in the Colon. Curr Tissue Microenviron Rep 2020;1:187-198. [DOI: 10.1007/s43152-020-00015-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
35 Liang C, Shangguan J, Yang L, Guo S. Downregulation of astrocyte elevated gene-1 expression inhibits the development of vasculogenic mimicry in gliomas. Exp Ther Med 2021;21:22. [PMID: 33235631 DOI: 10.3892/etm.2020.9454] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
36 de Faria Lainetti P, Brandi A, Leis Filho AF, Prado MCM, Kobayashi PE, Laufer-Amorim R, Fonseca-Alves CE. Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability in vitro and in vivo. Front Vet Sci 2020;7:583874. [PMID: 33195606 DOI: 10.3389/fvets.2020.583874] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
37 Aggarwal V, Miranda O, Johnston PA, Sant S. Three dimensional engineered models to study hypoxia biology in breast cancer. Cancer Lett 2020;490:124-42. [PMID: 32569616 DOI: 10.1016/j.canlet.2020.05.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
38 Hu B, Zhong BY, Zhang L, Dai C, Li W, Shen J, Huang P, Zhang S, Li Z, Ni CF. Occurrence of Vascular Lake Phenomenon Before Embolization for the Prediction of Lipiodol Uptake for Intermediate-Stage Hepatocellular Carcinoma Patients that Underwent cTACE. Cardiovasc Intervent Radiol 2020;43:1460-7. [PMID: 32500251 DOI: 10.1007/s00270-020-02501-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
39 Napoli S, Scuderi C, Gattuso G, Bella VD, Candido S, Basile MS, Libra M, Falzone L. Functional Roles of Matrix Metalloproteinases and Their Inhibitors in Melanoma. Cells 2020;9:E1151. [PMID: 32392801 DOI: 10.3390/cells9051151] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 14.3] [Reference Citation Analysis]
40 Luo Q, Wang J, Zhao W, Peng Z, Liu X, Li B, Zhang H, Shan B, Zhang C, Duan C. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol 2020;13:19. [PMID: 32169087 DOI: 10.1186/s13045-020-00858-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 19.7] [Reference Citation Analysis]
41 Wang M, Ye Q, Mao D, Li H. Research Progress in Liver-Regenerating Microenvironment and DNA Methylation in Hepatocellular Carcinoma: The Role of Traditional Chinese Medicine. Med Sci Monit 2020;26:e920310. [PMID: 32144233 DOI: 10.12659/MSM.920310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Haibe Y, Kreidieh M, El Hajj H, Khalifeh I, Mukherji D, Temraz S, Shamseddine A. Resistance Mechanisms to Anti-angiogenic Therapies in Cancer. Front Oncol 2020;10:221. [PMID: 32175278 DOI: 10.3389/fonc.2020.00221] [Cited by in Crossref: 121] [Cited by in F6Publishing: 138] [Article Influence: 40.3] [Reference Citation Analysis]
43 Hulin JA, Gubareva EA, Jarzebska N, Rodionov RN, Mangoni AA, Tommasi S. Inhibition of Dimethylarginine Dimethylaminohydrolase (DDAH) Enzymes as an Emerging Therapeutic Strategy to Target Angiogenesis and Vasculogenic Mimicry in Cancer. Front Oncol 2019;9:1455. [PMID: 31993367 DOI: 10.3389/fonc.2019.01455] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
44 Smeda M, Grosicki M, Chlopicki S. Local and systemic endothelial cell response to cancer: RKIP-mimetic therapy and endothelial safety. Prognostic and Therapeutic Applications of RKIP in Cancer 2020. [DOI: 10.1016/b978-0-12-819612-0.00013-4] [Reference Citation Analysis]
45 Stucker S, Chen J, Watt FE, Kusumbe AP. Bone Angiogenesis and Vascular Niche Remodeling in Stress, Aging, and Diseases. Front Cell Dev Biol 2020;8:602269. [PMID: 33324652 DOI: 10.3389/fcell.2020.602269] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 6.7] [Reference Citation Analysis]
46 Prado MCM, Macedo SAL, Guiraldelli GG, de Faria Lainetti P, Leis-Filho AF, Kobayashi PE, Laufer-Amorim R, Fonseca-Alves CE. Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors. Front Oncol 2019;9:1445. [PMID: 31921690 DOI: 10.3389/fonc.2019.01445] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
47 Brossa A, Buono L, Fallo S, Fiorio Pla A, Munaron L, Bussolati B. Alternative Strategies to Inhibit Tumor Vascularization. Int J Mol Sci 2019;20:E6180. [PMID: 31817884 DOI: 10.3390/ijms20246180] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
48 Leone P, Buonavoglia A, Fasano R, Solimando AG, De Re V, Cicco S, Vacca A, Racanelli V. Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs.J Clin Med. 2019;8. [PMID: 31757094 DOI: 10.3390/jcm8122030] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 12.0] [Reference Citation Analysis]
49 Zhang X, Zhang J, Zhou H, Fan G, Li Q. Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry. J Cancer 2019;10:6327-40. [PMID: 31772665 DOI: 10.7150/jca.34171] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 8.3] [Reference Citation Analysis]
50 Ayala-Domínguez L, Olmedo-Nieva L, Muñoz-Bello JO, Contreras-Paredes A, Manzo-Merino J, Martínez-Ramírez I, Lizano M. Mechanisms of Vasculogenic Mimicry in Ovarian Cancer. Front Oncol 2019;9:998. [PMID: 31612116 DOI: 10.3389/fonc.2019.00998] [Cited by in Crossref: 30] [Cited by in F6Publishing: 35] [Article Influence: 7.5] [Reference Citation Analysis]
51 Orecchia P, Balza E, Pietra G, Conte R, Bizzarri N, Ferrero S, Mingari MC, Carnemolla B. L19-IL2 Immunocytokine in Combination with the Anti-Syndecan-1 46F2SIP Antibody Format: A New Targeted Treatment Approach in an Ovarian Carcinoma Model. Cancers (Basel) 2019;11:E1232. [PMID: 31443604 DOI: 10.3390/cancers11091232] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
52 Jafarian AH, Kooshkiforooshani M, Rasoliostadi A, Mohamadian Roshan N. Vascular Mimicry Expression in Invasive Ductal Carcinoma; A New Technique for Prospect of Aggressiveness. Iran J Pathol 2019;14:232-5. [PMID: 31583000 DOI: 10.30699/ijp.2019.94997.1939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
53 Barreno L, Cáceres S, Alonso-Diez Á, Vicente-Montaña A, García ML, Clemente M, Illera JC, Peña L. Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines. BMC Cancer 2019;19:750. [PMID: 31362745 DOI: 10.1186/s12885-019-5955-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
54 Zhou Y, Song Z, Hu Q, Ji X, Zheng H, Wang X, Li Z. Evaluation of the Expression of Matrix Metalloproteinase-1 of Laryngeal Squamous Cell Carcinoma by Ultrasound Molecular Imaging. Front Pharmacol 2019;10:655. [PMID: 31275143 DOI: 10.3389/fphar.2019.00655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Castet F, Garcia-Mulero S, Sanz-Pamplona R, Cuellar A, Casanovas O, Caminal JM, Piulats JM. Uveal Melanoma, Angiogenesis and Immunotherapy, Is There Any Hope? Cancers (Basel) 2019;11:E834. [PMID: 31212986 DOI: 10.3390/cancers11060834] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
56 Salinas-Vera YM, Gallardo-Rincón D, García-Vázquez R, Hernández-de la Cruz ON, Marchat LA, González-Barrios JA, Ruíz-García E, Vázquez-Calzada C, Contreras-Sanzón E, Resendiz-Hernández M, Astudillo-de la Vega H, Cruz-Colin JL, Campos-Parra AD, López-Camarillo C. HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells. Front Oncol 2019;9:381. [PMID: 31157166 DOI: 10.3389/fonc.2019.00381] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
57 Senchukova MA, Makarova EV, Kalinin EA, Tkachev VV. Modern ideas about the origin, features of morphology, prognostic and predictive significance of tumor vessels. Rossijskij bioterapevtičeskij žurnal 2019;18:6-15. [DOI: 10.17650/1726-9784-2019-18-1-6-15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Katayama Y, Uchino J, Chihara Y, Tamiya N, Kaneko Y, Yamada T, Takayama K. Tumor Neovascularization and Developments in Therapeutics. Cancers (Basel) 2019;11:E316. [PMID: 30845711 DOI: 10.3390/cancers11030316] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 13.8] [Reference Citation Analysis]
59 Sambi M, Szewczuk MR. Introduction to the Acquisition of Resistance to Targeted Therapy. Resistance to Targeted Anti-Cancer Therapeutics 2019. [DOI: 10.1007/978-3-030-21477-7_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]